Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Egberts

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Therapie|April 27, 1999
Comparing therapeutic benefit and riskR H Meyboom, A C Egberts
Drug Safety|July 6, 2000
An ABC of drug-related problemsR H Meyboom, M Lindquist, A C Egberts
Journal of Analytical Toxicology|March 10, 1998
Performance of Abusign drugs-of-abuse slide tests with particluar emphasis on concentrations near the cutoff: comparison with FPIA-ADx and confirmation of results with GC-MSJ J Ros, M G Pelders, A C Egberts
Nederlands Tijdschrift Voor Geneeskunde|February 8, 1992
[Physician and pharmaceutical industry. II. Postmarketing surveillance]A C Egberts, A W Lenderink, H ter Steege
Nederlands Tijdschrift Voor Geneeskunde|September 24, 1999
[Clinical researchers and pharmaceutical industry. The examples of troglitazone and mibefradil]M L Bouvy, A C Egberts, H G Leufkens
The New Zealand Medical Journal|April 21, 1999
Mirtazapine and the granulocytes--so far so goodR H Meyboom, I R Edwards, A C Egberts
Journal of Pharmaceutical and Biomedical Analysis|March 4, 2000
Analysis of low concentration sufentanil citrate/bupivacaine hydrochloride admixtures, using solid phase extraction followed by high-performance liquid chromatographyK L Movig, M C Langen, A C Egberts
International Clinical Psychopharmacology|May 1, 1997
Serotonin syndrome attributed to tramadol addition to paroxetine therapyA C Egberts, J ter Borgh, C C Brodie-Meijer
Journal of Analytical Toxicology|September 22, 2000
Automated extraction of 11-nor-delta9-tetrahydrocannabinol carboxylic acid from urine samples using the ASPEC XL solid-phase extraction systemM C Langen, G A de Bijl, A C Egberts
European Journal of Pediatrics|December 11, 1999
Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasisR A de Moor, A C Egberts, C H Schröder
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Therapie|April 27, 1999
Comparing therapeutic benefit and riskR H Meyboom, A C Egberts
Drug Safety|July 6, 2000
An ABC of drug-related problemsR H Meyboom, M Lindquist, A C Egberts
Journal of Analytical Toxicology|March 10, 1998
Performance of Abusign drugs-of-abuse slide tests with particluar emphasis on concentrations near the cutoff: comparison with FPIA-ADx and confirmation of results with GC-MSJ J Ros, M G Pelders, A C Egberts
Nederlands Tijdschrift Voor Geneeskunde|February 8, 1992
[Physician and pharmaceutical industry. II. Postmarketing surveillance]A C Egberts, A W Lenderink, H ter Steege
Nederlands Tijdschrift Voor Geneeskunde|September 24, 1999
[Clinical researchers and pharmaceutical industry. The examples of troglitazone and mibefradil]M L Bouvy, A C Egberts, H G Leufkens
The New Zealand Medical Journal|April 21, 1999
Mirtazapine and the granulocytes--so far so goodR H Meyboom, I R Edwards, A C Egberts
Journal of Pharmaceutical and Biomedical Analysis|March 4, 2000
Analysis of low concentration sufentanil citrate/bupivacaine hydrochloride admixtures, using solid phase extraction followed by high-performance liquid chromatographyK L Movig, M C Langen, A C Egberts
International Clinical Psychopharmacology|May 1, 1997
Serotonin syndrome attributed to tramadol addition to paroxetine therapyA C Egberts, J ter Borgh, C C Brodie-Meijer
Journal of Analytical Toxicology|September 22, 2000
Automated extraction of 11-nor-delta9-tetrahydrocannabinol carboxylic acid from urine samples using the ASPEC XL solid-phase extraction systemM C Langen, G A de Bijl, A C Egberts
European Journal of Pediatrics|December 11, 1999
Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasisR A de Moor, A C Egberts, C H Schröder
Pageof 5